Global Meningococcal Vaccine Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027

Table of Contents

1 Report Overview
1.1 Study Scope and Definition
1.2 Research Methodology
1.2.1 Methodology/Research Approach
1.2.2 Data Source
1.3 Key Market Segments
1.4 Players Covered: Ranking by Meningococcal Vaccine Revenue
1.5 Market Analysis by Type
1.5.1 Global Meningococcal Vaccine Market Size Growth Rate by Type: 2021 VS 2027
1.5.2 Quadrivalent
1.5.3 Bivalent
1.5.4 Others
1.6 Market by Application
1.6.1 Global Meningococcal Vaccine Market Share by Application: 2022-2027
1.6.2 Pneumonia
1.6.3 Meningitis
1.6.4 Bacteremia
1.6.5 Others (Arthritis, Conjunctivitis, Urethritis)
1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections
1.7.2 Covid-19 Impact: Commodity Prices Indices
1.7.3 Covid-19 Impact: Global Major Government Policy
1.8 Study Objectives
1.9 Years Considered
2 Global Meningococcal Vaccine Market Trends and Growth Strategy
2.1 Market Top Trends
2.2 Market Drivers
2.3 Market Challenges
2.4 Porter's Five Forces Analysis
2.5 Market Growth Strategy
2.6 SWOT Analysis
3 Global Meningococcal Vaccine Market Players Profiles
3.1 Novartis
3.1.1 Novartis Company Profile
3.1.2 Novartis Meningococcal Vaccine Product Specification
3.1.3 Novartis Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.2 Bio-Med
3.2.1 Bio-Med Company Profile
3.2.2 Bio-Med Meningococcal Vaccine Product Specification
3.2.3 Bio-Med Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.3 CSL
3.3.1 CSL Company Profile
3.3.2 CSL Meningococcal Vaccine Product Specification
3.3.3 CSL Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 GSK
3.4.1 GSK Company Profile
3.4.2 GSK Meningococcal Vaccine Product Specification
3.4.3 GSK Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Serum Institute of India
3.5.1 Serum Institute of India Company Profile
3.5.2 Serum Institute of India Meningococcal Vaccine Product Specification
3.5.3 Serum Institute of India Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 Merck
3.6.1 Merck Company Profile
3.6.2 Merck Meningococcal Vaccine Product Specification
3.6.3 Merck Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Hualan Bio
3.7.1 Hualan Bio Company Profile
3.7.2 Hualan Bio Meningococcal Vaccine Product Specification
3.7.3 Hualan Bio Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 JN International Medical Corporation
3.8.1 JN International Medical Corporation Company Profile
3.8.2 JN International Medical Corporation Meningococcal Vaccine Product Specification
3.8.3 JN International Medical Corporation Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Baxter
3.9.1 Baxter Company Profile
3.9.2 Baxter Meningococcal Vaccine Product Specification
3.9.3 Baxter Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 China National Biotec Group
3.10.1 China National Biotec Group Company Profile
3.10.2 China National Biotec Group Meningococcal Vaccine Product Specification
3.10.3 China National Biotec Group Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 Walvax
3.11.1 Walvax Company Profile
3.11.2 Walvax Meningococcal Vaccine Product Specification
3.11.3 Walvax Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Zhifei
3.12.1 Zhifei Company Profile
3.12.2 Zhifei Meningococcal Vaccine Product Specification
3.12.3 Zhifei Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
4 Global Meningococcal Vaccine Market Competition by Market Players
4.1 Global Meningococcal Vaccine Production Capacity Market Share by Market Players (2016-2021)
4.2 Global Meningococcal Vaccine Revenue Market Share by Market Players (2016-2021)
4.3 Global Meningococcal Vaccine Average Price by Market Players (2016-2021)
5 Global Meningococcal Vaccine Production by Regions (2016-2021)
5.1 North America
5.1.1 North America Meningococcal Vaccine Market Size (2016-2021)
5.1.2 Meningococcal Vaccine Key Players in North America (2016-2021)
5.1.3 North America Meningococcal Vaccine Market Size by Type (2016-2021)
5.1.4 North America Meningococcal Vaccine Market Size by Application (2016-2021)
5.2 East Asia
5.2.1 East Asia Meningococcal Vaccine Market Size (2016-2021)
5.2.2 Meningococcal Vaccine Key Players in East Asia (2016-2021)
5.2.3 East Asia Meningococcal Vaccine Market Size by Type (2016-2021)
5.2.4 East Asia Meningococcal Vaccine Market Size by Application (2016-2021)
5.3 Europe
5.3.1 Europe Meningococcal Vaccine Market Size (2016-2021)
5.3.2 Meningococcal Vaccine Key Players in Europe (2016-2021)
5.3.3 Europe Meningococcal Vaccine Market Size by Type (2016-2021)
5.3.4 Europe Meningococcal Vaccine Market Size by Application (2016-2021)
5.4 South Asia
5.4.1 South Asia Meningococcal Vaccine Market Size (2016-2021)
5.4.2 Meningococcal Vaccine Key Players in South Asia (2016-2021)
5.4.3 South Asia Meningococcal Vaccine Market Size by Type (2016-2021)
5.4.4 South Asia Meningococcal Vaccine Market Size by Application (2016-2021)
5.5 Southeast Asia
5.5.1 Southeast Asia Meningococcal Vaccine Market Size (2016-2021)
5.5.2 Meningococcal Vaccine Key Players in Southeast Asia (2016-2021)
5.5.3 Southeast Asia Meningococcal Vaccine Market Size by Type (2016-2021)
5.5.4 Southeast Asia Meningococcal Vaccine Market Size by Application (2016-2021)
5.6 Middle East
5.6.1 Middle East Meningococcal Vaccine Market Size (2016-2021)
5.6.2 Meningococcal Vaccine Key Players in Middle East (2016-2021)
5.6.3 Middle East Meningococcal Vaccine Market Size by Type (2016-2021)
5.6.4 Middle East Meningococcal Vaccine Market Size by Application (2016-2021)
5.7 Africa
5.7.1 Africa Meningococcal Vaccine Market Size (2016-2021)
5.7.2 Meningococcal Vaccine Key Players in Africa (2016-2021)
5.7.3 Africa Meningococcal Vaccine Market Size by Type (2016-2021)
5.7.4 Africa Meningococcal Vaccine Market Size by Application (2016-2021)
5.8 Oceania
5.8.1 Oceania Meningococcal Vaccine Market Size (2016-2021)
5.8.2 Meningococcal Vaccine Key Players in Oceania (2016-2021)
5.8.3 Oceania Meningococcal Vaccine Market Size by Type (2016-2021)
5.8.4 Oceania Meningococcal Vaccine Market Size by Application (2016-2021)
5.9 South America
5.9.1 South America Meningococcal Vaccine Market Size (2016-2021)
5.9.2 Meningococcal Vaccine Key Players in South America (2016-2021)
5.9.3 South America Meningococcal Vaccine Market Size by Type (2016-2021)
5.9.4 South America Meningococcal Vaccine Market Size by Application (2016-2021)
5.10 Rest of the World
5.10.1 Rest of the World Meningococcal Vaccine Market Size (2016-2021)
5.10.2 Meningococcal Vaccine Key Players in Rest of the World (2016-2021)
5.10.3 Rest of the World Meningococcal Vaccine Market Size by Type (2016-2021)
5.10.4 Rest of the World Meningococcal Vaccine Market Size by Application (2016-2021)
6 Global Meningococcal Vaccine Consumption by Region (2016-2021)
6.1 North America
6.1.1 North America Meningococcal Vaccine Consumption by Countries
6.1.2 United States
6.1.3 Canada
6.1.4 Mexico
6.2 East Asia
6.2.1 East Asia Meningococcal Vaccine Consumption by Countries
6.2.2 China
6.2.3 Japan
6.2.4 South Korea
6.3 Europe
6.3.1 Europe Meningococcal Vaccine Consumption by Countries
6.3.2 Germany
6.3.3 United Kingdom
6.3.4 France
6.3.5 Italy
6.3.6 Russia
6.3.7 Spain
6.3.8 Netherlands
6.3.9 Switzerland
6.3.10 Poland
6.4 South Asia
6.4.1 South Asia Meningococcal Vaccine Consumption by Countries
6.4.2 India
6.5 Southeast Asia
6.5.1 Southeast Asia Meningococcal Vaccine Consumption by Countries
6.5.2 Indonesia
6.5.3 Thailand
6.5.4 Singapore
6.5.5 Malaysia
6.5.6 Philippines
6.6 Middle East
6.6.1 Middle East Meningococcal Vaccine Consumption by Countries
6.6.2 Turkey
6.6.3 Saudi Arabia
6.6.4 Iran
6.6.5 United Arab Emirates
6.7 Africa
6.7.1 Africa Meningococcal Vaccine Consumption by Countries
6.7.2 Nigeria
6.7.3 South Africa
6.8 Oceania
6.8.1 Oceania Meningococcal Vaccine Consumption by Countries
6.8.2 Australia
6.9 South America
6.9.1 South America Meningococcal Vaccine Consumption by Countries
6.9.2 Brazil
6.9.3 Argentina
6.10 Rest of the World
6.10.1 Rest of the World Meningococcal Vaccine Consumption by Countries
7 Global Meningococcal Vaccine Production Forecast by Regions (2022-2027)
7.1 Global Forecasted Production of Meningococcal Vaccine (2022-2027)
7.2 Global Forecasted Revenue of Meningococcal Vaccine (2022-2027)
7.3 Global Forecasted Price of Meningococcal Vaccine (2022-2027)
7.4 Global Forecasted Production of Meningococcal Vaccine by Region (2022-2027)
7.4.1 North America Meningococcal Vaccine Production, Revenue Forecast (2022-2027)
7.4.2 East Asia Meningococcal Vaccine Production, Revenue Forecast (2022-2027)
7.4.3 Europe Meningococcal Vaccine Production, Revenue Forecast (2022-2027)
7.4.4 South Asia Meningococcal Vaccine Production, Revenue Forecast (2022-2027)
7.4.5 Southeast Asia Meningococcal Vaccine Production, Revenue Forecast (2022-2027)
7.4.6 Middle East Meningococcal Vaccine Production, Revenue Forecast (2022-2027)
7.4.7 Africa Meningococcal Vaccine Production, Revenue Forecast (2022-2027)
7.4.8 Oceania Meningococcal Vaccine Production, Revenue Forecast (2022-2027)
7.4.9 South America Meningococcal Vaccine Production, Revenue Forecast (2022-2027)
7.4.10 Rest of the World Meningococcal Vaccine Production, Revenue Forecast (2022-2027)
7.5 Forecast by Type and by Application (2022-2027)
7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
7.5.2 Global Forecasted Consumption of Meningococcal Vaccine by Application (2022-2027)
8 Global Meningococcal Vaccine Consumption Forecast by Regions (2022-2027)
8.1 North America Forecasted Consumption of Meningococcal Vaccine by Country
8.2 East Asia Market Forecasted Consumption of Meningococcal Vaccine by Country
8.3 Europe Market Forecasted Consumption of Meningococcal Vaccine by Countriy
8.4 South Asia Forecasted Consumption of Meningococcal Vaccine by Country
8.5 Southeast Asia Forecasted Consumption of Meningococcal Vaccine by Country
8.6 Middle East Forecasted Consumption of Meningococcal Vaccine by Country
8.7 Africa Forecasted Consumption of Meningococcal Vaccine by Country
8.8 Oceania Forecasted Consumption of Meningococcal Vaccine by Country
8.9 South America Forecasted Consumption of Meningococcal Vaccine by Country
8.10 Rest of the world Forecasted Consumption of Meningococcal Vaccine by Country
9 Global Meningococcal Vaccine Sales by Type (2016-2027)
9.1 Global Meningococcal Vaccine Historic Market Size by Type (2016-2021)
9.2 Global Meningococcal Vaccine Forecasted Market Size by Type (2022-2027)
10 Global Meningococcal Vaccine Consumption by Application (2016-2027)
10.1 Global Meningococcal Vaccine Historic Market Size by Application (2016-2021)
10.2 Global Meningococcal Vaccine Forecasted Market Size by Application (2022-2027)
11 Global Meningococcal Vaccine Manufacturing Cost Analysis
11.1 Meningococcal Vaccine Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.3 Manufacturing Process Analysis of Meningococcal Vaccine
12 Global Meningococcal Vaccine Marketing Channel, Distributors, Customers and Supply Chain
12.1 Marketing Channel
12.2 Meningococcal Vaccine Distributors List
12.3 Meningococcal Vaccine Customers
12.4 Meningococcal Vaccine Supply Chain Analysis
13 Analyst's Viewpoints/Conclusions
14 Disclaimer

List of Figure

Figure 1. Product Figure
Figure 2. Global Meningococcal Vaccine Market Share by Type: 2021 VS 2027
Figure 3. Global Meningococcal Vaccine Market Share by Application: 2021 VS 2027
Figure 4. North America Meningococcal Vaccine Market Size YoY Growth (2016-2021) (USD Million)
Figure 5. North America Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 6. North America Meningococcal Vaccine Consumption Market Share by Countries in 2021
Figure 7. United States Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 8. Canada Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 9. Mexico Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 10. East Asia Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 11. East Asia Meningococcal Vaccine Consumption Market Share by Countries in 2021
Figure 12. China Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 13. Japan Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 14. South Korea Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 15. Europe Meningococcal Vaccine Consumption and Growth Rate
Figure 16. Europe Meningococcal Vaccine Consumption Market Share by Region in 2021
Figure 17. Germany Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 18. United Kingdom Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 19. France Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 20. Italy Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 21. Russia Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 22. Spain Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 23. Netherlands Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 24. Switzerland Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 25. Poland Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 26. South Asia Meningococcal Vaccine Consumption and Growth Rate
Figure 27. South Asia Meningococcal Vaccine Consumption Market Share by Countries in 2021
Figure 28. India Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 29. Southeast Asia Meningococcal Vaccine Consumption and Growth Rate
Figure 30. Southeast Asia Meningococcal Vaccine Consumption Market Share by Countries in 2021
Figure 31. Indonesia Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 32. Thailand Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 33. Singapore Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 34. Malaysia Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 35. Philippines Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 36. Middle East Meningococcal Vaccine Consumption and Growth Rate
Figure 37. Middle East Meningococcal Vaccine Consumption Market Share by Countries in 2021
Figure 38. Turkey Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 39. Saudi Arabia Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 40. Iran Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 41. United Arab Emirates Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 42. Africa Meningococcal Vaccine Consumption and Growth Rate
Figure 43. Africa Meningococcal Vaccine Consumption Market Share by Countries in 2021
Figure 44. Nigeria Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 45. South Africa Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 46. Oceania Meningococcal Vaccine Consumption and Growth Rate
Figure 47. Oceania Meningococcal Vaccine Consumption Market Share by Countries in 2021
Figure 48. Australia Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 49. South America Meningococcal Vaccine Consumption and Growth Rate
Figure 50. South America Meningococcal Vaccine Consumption Market Share by Countries in 2021
Figure 51. Brazil Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 52. Argentina Meningococcal Vaccine Consumption and Growth Rate (2016-2021)
Figure 53. Rest of the World Meningococcal Vaccine Consumption and Growth Rate
Figure 54. Rest of the World Meningococcal Vaccine Consumption Market Share by Countries in 2021
Figure 55. Global Meningococcal Vaccine Production Capacity Growth Rate Forecast (2022-2027)
Figure 56. Global Meningococcal Vaccine Revenue Growth Rate Forecast (2022-2027)
Figure 57. Global Meningococcal Vaccine Price and Trend Forecast (2022-2027)
Figure 58. North America Meningococcal Vaccine Production Growth Rate Forecast (2022-2027)
Figure 59. North America Meningococcal Vaccine Revenue Growth Rate Forecast (2022-2027)
Figure 60. East Asia Meningococcal Vaccine Production Growth Rate Forecast (2022-2027)
Figure 61. East Asia Meningococcal Vaccine Revenue Growth Rate Forecast (2022-2027)
Figure 62. Europe Meningococcal Vaccine Production Growth Rate Forecast (2022-2027)
Figure 63. Europe Meningococcal Vaccine Revenue Growth Rate Forecast (2022-2027)
Figure 64. South Asia Meningococcal Vaccine Production Growth Rate Forecast (2022-2027)
Figure 65. South Asia Meningococcal Vaccine Revenue Growth Rate Forecast (2022-2027)
Figure 66. Southeast Asia Meningococcal Vaccine Production Growth Rate Forecast (2022-2027)
Figure 67. Southeast Asia Meningococcal Vaccine Revenue Growth Rate Forecast (2022-2027)
Figure 68. Middle East Meningococcal Vaccine Production Growth Rate Forecast (2022-2027)
Figure 69. Middle East Meningococcal Vaccine Revenue Growth Rate Forecast (2022-2027)
Figure 70. Africa Meningococcal Vaccine Production Growth Rate Forecast (2022-2027)
Figure 71. Africa Meningococcal Vaccine Revenue Growth Rate Forecast (2022-2027)
Figure 72. Oceania Meningococcal Vaccine Production Growth Rate Forecast (2022-2027)
Figure 73. Oceania Meningococcal Vaccine Revenue Growth Rate Forecast (2022-2027)
Figure 74. South America Meningococcal Vaccine Production Growth Rate Forecast (2022-2027)
Figure 75. South America Meningococcal Vaccine Revenue Growth Rate Forecast (2022-2027)
Figure 76. Rest of the World Meningococcal Vaccine Production Growth Rate Forecast (2022-2027)
Figure 77. Rest of the World Meningococcal Vaccine Revenue Growth Rate Forecast (2022-2027)
Figure 78. North America Meningococcal Vaccine Consumption Forecast 2022-2027
Figure 79. East Asia Meningococcal Vaccine Consumption Forecast 2022-2027
Figure 80. Europe Meningococcal Vaccine Consumption Forecast 2022-2027
Figure 81. South Asia Meningococcal Vaccine Consumption Forecast 2022-2027
Figure 82. Southeast Asia Meningococcal Vaccine Consumption Forecast 2022-2027
Figure 83. Middle East Meningococcal Vaccine Consumption Forecast 2022-2027
Figure 84. Africa Meningococcal Vaccine Consumption Forecast 2022-2027
Figure 85. Oceania Meningococcal Vaccine Consumption Forecast 2022-2027
Figure 86. South America Meningococcal Vaccine Consumption Forecast 2022-2027
Figure 87. Rest of the world Meningococcal Vaccine Consumption Forecast 2022-2027
Figure 88. Manufacturing Cost Structure of Meningococcal Vaccine
Figure 89. Manufacturing Process Analysis of Meningococcal Vaccine
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Meningococcal Vaccine Supply Chain Analysis

List of Table

Table 1. Research Programs/Design for This Report
Table 2. Key Data Information from Secondary Sources
Table 3. Key Executives Interviewed
Table 4. Key Data Information from Primary Sources
Table 5. Key Players Covered: Ranking by Meningococcal Vaccine Revenue (USD Million) 2016-2021
Table 6. Global Meningococcal Vaccine Market Size by Type (USD Million): 2022-2027
Table 7. Quadrivalent Features
Table 8. Bivalent Features
Table 9. Others Features
Table 16. Global Meningococcal Vaccine Market Size by Application (USD Million): 2022-2027
Table 17. Pneumonia Case Studies
Table 18. Meningitis Case Studies
Table 19. Bacteremia Case Studies
Table 20. Others (Arthritis, Conjunctivitis, Urethritis) Case Studies
Table 26. Overview of the World Economic Outlook Projections
Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 32. Commodity Prices-Metals Price Indices
Table 33. Commodity Prices- Precious Metal Price Indices
Table 34. Commodity Prices- Agricultural Raw Material Price Indices
Table 35. Commodity Prices- Food and Beverage Price Indices
Table 36. Commodity Prices- Fertilizer Price Indices
Table 37. Commodity Prices- Energy Price Indices
Table 38. G20+: Economic Policy Responses to COVID-19
Table 39. Covid-19 Impact: Global Major Government Policy
Table 40. Meningococcal Vaccine Report Years Considered
Table 41. Market Top Trends
Table 42. Key Drivers: Impact Analysis
Table 43. Key Challenges
Table 44. Porter's Five Forces Analysis
Table 45. Meningococcal Vaccine Market Growth Strategy
Table 46. Meningococcal Vaccine SWOT Analysis
Table 47. Novartis Meningococcal Vaccine Product Specification
Table 48. Novartis Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 49. Bio-Med Meningococcal Vaccine Product Specification
Table 50. Bio-Med Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 51. CSL Meningococcal Vaccine Product Specification
Table 52. CSL Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 53. GSK Meningococcal Vaccine Product Specification
Table 54. Table GSK Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 55. Serum Institute of India Meningococcal Vaccine Product Specification
Table 56. Serum Institute of India Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 57. Merck Meningococcal Vaccine Product Specification
Table 58. Merck Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 59. Hualan Bio Meningococcal Vaccine Product Specification
Table 60. Hualan Bio Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 61. JN International Medical Corporation Meningococcal Vaccine Product Specification
Table 62. JN International Medical Corporation Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 63. Baxter Meningococcal Vaccine Product Specification
Table 64. Baxter Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 65. China National Biotec Group Meningococcal Vaccine Product Specification
Table 66. China National Biotec Group Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 67. Walvax Meningococcal Vaccine Product Specification
Table 68. Walvax Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 69. Zhifei Meningococcal Vaccine Product Specification
Table 70. Zhifei Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 147. Global Meningococcal Vaccine Production Capacity by Market Players
Table 148. Global Meningococcal Vaccine Production by Market Players (2016-2021)
Table 149. Global Meningococcal Vaccine Production Market Share by Market Players (2016-2021)
Table 150. Global Meningococcal Vaccine Revenue by Market Players (2016-2021)
Table 151. Global Meningococcal Vaccine Revenue Share by Market Players (2016-2021)
Table 152. Global Market Meningococcal Vaccine Average Price of Key Market Players (2016-2021)
Table 153. North America Key Players Meningococcal Vaccine Revenue (2016-2021) (USD Million)
Table 154. North America Key Players Meningococcal Vaccine Market Share (2016-2021)
Table 155. North America Meningococcal Vaccine Market Size by Type (2016-2021) (USD Million)
Table 156. North America Meningococcal Vaccine Market Share by Type (2016-2021)
Table 157. North America Meningococcal Vaccine Market Size by Application (2016-2021) (USD Million)
Table 158. North America Meningococcal Vaccine Market Share by Application (2016-2021)
Table 159. East Asia Meningococcal Vaccine Market Size YoY Growth (2016-2021) (USD Million)
Table 160. East Asia Key Players Meningococcal Vaccine Revenue (2016-2021) (USD Million)
Table 161. East Asia Key Players Meningococcal Vaccine Market Share (2016-2021)
Table 162. East Asia Meningococcal Vaccine Market Size by Type (2016-2021) (USD Million)
Table 163. East Asia Meningococcal Vaccine Market Share by Type (2016-2021)
Table 164. East Asia Meningococcal Vaccine Market Size by Application (2016-2021) (USD Million)
Table 165. East Asia Meningococcal Vaccine Market Share by Application (2016-2021)
Table 166. Europe Meningococcal Vaccine Market Size YoY Growth (2016-2021) (USD Million)
Table 167. Europe Key Players Meningococcal Vaccine Revenue (2016-2021) (USD Million)
Table 168. Europe Key Players Meningococcal Vaccine Market Share (2016-2021)
Table 169. Europe Meningococcal Vaccine Market Size by Type (2016-2021) (USD Million)
Table 170. Europe Meningococcal Vaccine Market Share by Type (2016-2021)
Table 171. Europe Meningococcal Vaccine Market Size by Application (2016-2021) (USD Million)
Table 172. Europe Meningococcal Vaccine Market Share by Application (2016-2021)
Table 173. South Asia Meningococcal Vaccine Market Size YoY Growth (2016-2021) (USD Million)
Table 174. South Asia Key Players Meningococcal Vaccine Revenue (2016-2021) (USD Million)
Table 175. South Asia Key Players Meningococcal Vaccine Market Share (2016-2021)
Table 176. South Asia Meningococcal Vaccine Market Size by Type (2016-2021) (USD Million)
Table 177. South Asia Meningococcal Vaccine Market Share by Type (2016-2021)
Table 178. South Asia Meningococcal Vaccine Market Size by Application (2016-2021) (USD Million)
Table 179. South Asia Meningococcal Vaccine Market Share by Application (2016-2021)
Table 180. Southeast Asia Meningococcal Vaccine Market Size YoY Growth (2016-2021) (USD Million)
Table 181. Southeast Asia Key Players Meningococcal Vaccine Revenue (2016-2021) (USD Million)
Table 182. Southeast Asia Key Players Meningococcal Vaccine Market Share (2016-2021)
Table 183. Southeast Asia Meningococcal Vaccine Market Size by Type (2016-2021) (USD Million)
Table 184. Southeast Asia Meningococcal Vaccine Market Share by Type (2016-2021)
Table 185. Southeast Asia Meningococcal Vaccine Market Size by Application (2016-2021) (USD Million)
Table 186. Southeast Asia Meningococcal Vaccine Market Share by Application (2016-2021)
Table 187. Middle East Meningococcal Vaccine Market Size YoY Growth (2016-2021) (USD Million)
Table 188. Middle East Key Players Meningococcal Vaccine Revenue (2016-2021) (USD Million)
Table 189. Middle East Key Players Meningococcal Vaccine Market Share (2016-2021)
Table 190. Middle East Meningococcal Vaccine Market Size by Type (2016-2021) (USD Million)
Table 191. Middle East Meningococcal Vaccine Market Share by Type (2016-2021)
Table 192. Middle East Meningococcal Vaccine Market Size by Application (2016-2021) (USD Million)
Table 193. Middle East Meningococcal Vaccine Market Share by Application (2016-2021)
Table 194. Africa Meningococcal Vaccine Market Size YoY Growth (2016-2021) (USD Million)
Table 195. Africa Key Players Meningococcal Vaccine Revenue (2016-2021) (USD Million)
Table 196. Africa Key Players Meningococcal Vaccine Market Share (2016-2021)
Table 197. Africa Meningococcal Vaccine Market Size by Type (2016-2021) (USD Million)
Table 198. Africa Meningococcal Vaccine Market Share by Type (2016-2021)
Table 199. Africa Meningococcal Vaccine Market Size by Application (2016-2021) (USD Million)
Table 200. Africa Meningococcal Vaccine Market Share by Application (2016-2021)
Table 201. Oceania Meningococcal Vaccine Market Size YoY Growth (2016-2021) (USD Million)
Table 202. Oceania Key Players Meningococcal Vaccine Revenue (2016-2021) (USD Million)
Table 203. Oceania Key Players Meningococcal Vaccine Market Share (2016-2021)
Table 204. Oceania Meningococcal Vaccine Market Size by Type (2016-2021) (USD Million)
Table 205. Oceania Meningococcal Vaccine Market Share by Type (2016-2021)
Table 206. Oceania Meningococcal Vaccine Market Size by Application (2016-2021) (USD Million)
Table 207. Oceania Meningococcal Vaccine Market Share by Application (2016-2021)
Table 208. South America Meningococcal Vaccine Market Size YoY Growth (2016-2021) (USD Million)
Table 209. South America Key Players Meningococcal Vaccine Revenue (2016-2021) (USD Million)
Table 210. South America Key Players Meningococcal Vaccine Market Share (2016-2021)
Table 211. South America Meningococcal Vaccine Market Size by Type (2016-2021) (USD Million)
Table 212. South America Meningococcal Vaccine Market Share by Type (2016-2021)
Table 213. South America Meningococcal Vaccine Market Size by Application (2016-2021) (USD Million)
Table 214. South America Meningococcal Vaccine Market Share by Application (2016-2021)
Table 215. Rest of the World Meningococcal Vaccine Market Size YoY Growth (2016-2021) (USD Million)
Table 216. Rest of the World Key Players Meningococcal Vaccine Revenue (2016-2021) (USD Million)
Table 217. Rest of the World Key Players Meningococcal Vaccine Market Share (2016-2021)
Table 218. Rest of the World Meningococcal Vaccine Market Size by Type (2016-2021) (USD Million)
Table 219. Rest of the World Meningococcal Vaccine Market Share by Type (2016-2021)
Table 220. Rest of the World Meningococcal Vaccine Market Size by Application (2016-2021) (USD Million)
Table 221. Rest of the World Meningococcal Vaccine Market Share by Application (2016-2021)
Table 222. North America Meningococcal Vaccine Consumption by Countries (2016-2021)
Table 223. East Asia Meningococcal Vaccine Consumption by Countries (2016-2021)
Table 224. Europe Meningococcal Vaccine Consumption by Region (2016-2021)
Table 225. South Asia Meningococcal Vaccine Consumption by Countries (2016-2021)
Table 226. Southeast Asia Meningococcal Vaccine Consumption by Countries (2016-2021)
Table 227. Middle East Meningococcal Vaccine Consumption by Countries (2016-2021)
Table 228. Africa Meningococcal Vaccine Consumption by Countries (2016-2021)
Table 229. Oceania Meningococcal Vaccine Consumption by Countries (2016-2021)
Table 230. South America Meningococcal Vaccine Consumption by Countries (2016-2021)
Table 231. Rest of the World Meningococcal Vaccine Consumption by Countries (2016-2021)
Table 232. Global Meningococcal Vaccine Production Forecast by Region (2022-2027)
Table 233. Global Meningococcal Vaccine Sales Volume Forecast by Type (2022-2027)
Table 234. Global Meningococcal Vaccine Sales Volume Market Share Forecast by Type (2022-2027)
Table 235. Global Meningococcal Vaccine Sales Revenue Forecast by Type (2022-2027)
Table 236. Global Meningococcal Vaccine Sales Revenue Market Share Forecast by Type (2022-2027)
Table 237. Global Meningococcal Vaccine Sales Price Forecast by Type (2022-2027)
Table 238. Global Meningococcal Vaccine Consumption Volume Forecast by Application (2022-2027)
Table 239. Global Meningococcal Vaccine Consumption Value Forecast by Application (2022-2027)
Table 240. North America Meningococcal Vaccine Consumption Forecast 2022-2027 by Country
Table 241. East Asia Meningococcal Vaccine Consumption Forecast 2022-2027 by Country
Table 242. Europe Meningococcal Vaccine Consumption Forecast 2022-2027 by Country
Table 243. South Asia Meningococcal Vaccine Consumption Forecast 2022-2027 by Country
Table 244. Southeast Asia Meningococcal Vaccine Consumption Forecast 2022-2027 by Country
Table 245. Middle East Meningococcal Vaccine Consumption Forecast 2022-2027 by Country
Table 246. Africa Meningococcal Vaccine Consumption Forecast 2022-2027 by Country
Table 247. Oceania Meningococcal Vaccine Consumption Forecast 2022-2027 by Country
Table 248. South America Meningococcal Vaccine Consumption Forecast 2022-2027 by Country
Table 249. Rest of the world Meningococcal Vaccine Consumption Forecast 2022-2027 by Country
Table 250. Global Meningococcal Vaccine Market Size by Type (2016-2021) (USD Million)
Table 251. Global Meningococcal Vaccine Revenue Market Share by Type (2016-2021)
Table 252. Global Meningococcal Vaccine Forecasted Market Size by Type (2022-2027) (USD Million)
Table 253. Global Meningococcal Vaccine Revenue Market Share by Type (2022-2027)
Table 254. Global Meningococcal Vaccine Market Size by Application (2016-2021) (USD Million)
Table 255. Global Meningococcal Vaccine Revenue Market Share by Application (2016-2021)
Table 256. Global Meningococcal Vaccine Forecasted Market Size by Application (2022-2027) (USD Million)
Table 257. Global Meningococcal Vaccine Revenue Market Share by Application (2022-2027)
Table 258. Meningococcal Vaccine Distributors List
Table 259. Meningococcal Vaccine Customers List